Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Neoplasms of the CNS

  Free Subscription


Articles published in Cancer

Retrieve available abstracts of 54 articles:
HTML format
Text format



Single Articles


    May 2019
  1. PRINTZ C
    First person profile: Michelle Monje, MD, PhD: Her research on how normal brain functions contribute to pediatric brain tumors may help physicians fight a lethal childhood cancer.
    Cancer. 2019;125:1397-1398.
    PubMed     Text format    


    February 2019
  2. MARAKA S, Groves MD, Penas-Prado M
    Reply to Unexpectedly low rates of neuropsychiatric adverse effects associated with mefloquine repurposed for the treatment of glioblastoma.
    Cancer. 2019 Feb 1. doi: 10.1002/cncr.31960.
    PubMed     Text format    


  3. NEVIN RL
    Unexpectedly low rates of neuropsychiatric adverse effects associated with mefloquine repurposed for the treatment of glioblastoma.
    Cancer. 2019 Feb 1. doi: 10.1002/cncr.31961.
    PubMed     Text format    


    January 2019
  4. PRINTZ C
    Pediatric computed tomography scans: Weighing the risks and benefits: A new study suggests that computed tomography-related radiation may increase the risk of brain tumors, but the conversation, physicians say, is complex-and far from settled.
    Cancer. 2019;125:171-173.
    PubMed     Text format    


  5. LIU APY, Hastings C, Wu S, Bass JK, et al
    Treatment burden and long-term health deficits of patients with low-grade gliomas or glioneuronal tumors diagnosed during the first year of life.
    Cancer. 2019 Jan 8. doi: 10.1002/cncr.31918.
    PubMed     Text format     Abstract available


    December 2018
  6. GEURTS M, van den Bent MJ
    On high-risk, low-grade glioma: What distinguishes high from low?
    Cancer. 2018 Dec 4. doi: 10.1002/cncr.31834.
    PubMed     Text format    


    November 2018
  7. PRINTZ C
    Can a repurposed vaccine fight cancer?: Use of the poliovirus vaccine to target brain tumors draws interest.
    Cancer. 2018;124:4273-4274.
    PubMed     Text format    


    October 2018
  8. MARAKA S, Groves MD, Mammoser AG, Melguizo-Gavilanes I, et al
    Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma.
    Cancer. 2018 Oct 25. doi: 10.1002/cncr.31811.
    PubMed     Text format     Abstract available


    September 2018
  9. KUMAR R, Liu APY, Orr BA, Northcott PA, et al
    Advances in the classification of pediatric brain tumors through dna methylation profiling: from research tool to frontline diagnostic.
    Cancer. 2018 Sep 26. doi: 10.1002/cncr.31583.
    PubMed     Text format     Abstract available


    August 2018
  10. PRESS RH, Zhang C, Cassidy RJ, Ferris MJ, et al
    Targeted Sequencing and Intracranial Outcomes of Patients With Lung Adenocarcinoma Brain Metastases Treated With Radiotherapy.
    Cancer. 2018 Aug 18. doi: 10.1002/cncr.31589.
    PubMed     Text format     Abstract available


    June 2018
  11. KAMRAN SC, Goldberg SI, Kuhlthau KA, Lawell MP, et al
    Quality of life in patients with proton-treated pediatric medulloblastoma: Results of a prospective assessment with 5-year follow-up.
    Cancer. 2018 Jun 15. doi: 10.1002/cncr.31575.
    PubMed     Text format     Abstract available


    April 2018
  12. WICK W, Winkler F
    Regimen of procarbazine, lomustine, and vincristine versus temozolomide for gliomas.
    Cancer. 2018 Apr 26. doi: 10.1002/cncr.31371.
    PubMed     Text format    


    March 2018
  13. ZUREICK AH, Evans CL, Niemierko A, Grieco JA, et al
    Left hippocampal dosimetry correlates with visual and verbal memory outcomes in survivors of pediatric brain tumors.
    Cancer. 2018 Mar 2. doi: 10.1002/cncr.31143.
    PubMed     Text format     Abstract available


    January 2018
  14. WELLER M
    Where does O(6) -methylguanine DNA methyltransferase promoter methylation assessment place temozolomide in the future standards of care for glioblastoma?
    Cancer. 2018 Jan 30. doi: 10.1002/cncr.31244.
    PubMed     Text format    


  15. SCHIFF D, Jaeckle KA, Anderson SK, Galanis E, et al
    Phase 1/2 trial of temsirolimus and sorafenib in the treatment of patients with recurrent glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572.
    Cancer. 2018 Jan 3. doi: 10.1002/cncr.31219.
    PubMed     Text format     Abstract available


  16. WANG N, Bertalan MS, Brastianos PK
    Leptomeningeal metastasis from systemic cancer: Review and update on management.
    Cancer. 2018;124:21-35.
    PubMed     Text format     Abstract available


    December 2017
  17. REARDON DA, Lassman AB, Schiff D, Yunus SA, et al
    Phase 2 and biomarker study of trebananib, an angiopoietin-blocking peptibody, with and without bevacizumab for patients with recurrent glioblastoma.
    Cancer. 2017 Dec 19. doi: 10.1002/cncr.31172.
    PubMed     Text format     Abstract available


  18. JHAVERI J, Liu Y, Chowdhary M, Buchwald ZS, et al
    Is less more? Comparing chemotherapy alone with chemotherapy and radiation for high-risk grade 2 glioma: An analysis of the National Cancer Data Base.
    Cancer. 2017 Dec 4. doi: 10.1002/cncr.31158.
    PubMed     Text format     Abstract available


    November 2017
  19. GEORGAKIS MK, Papathoma P, Ryzhov A, Zivkovic-Perisic S, et al
    Malignant central nervous system tumors among adolescents and young adults (15-39 years old) in 14 Southern-Eastern European registries and the US Surveillance, Epidemiology, and End Results program: Mortality and survival patterns.
    Cancer. 2017;123:4458-4471.
    PubMed     Text format     Abstract available


  20. RYDZEWSKI NR, Lesniak MS, Chandler JP, Kalapurakal JA, et al
    Gross total resection and adjuvant radiotherapy most significant predictors of improved survival in patients with atypical meningioma.
    Cancer. 2017 Nov 13. doi: 10.1002/cncr.31088.
    PubMed     Text format     Abstract available


    October 2017
  21. SHEN CJ, Hu C, Ladra MM, Narang AK, et al
    Socioeconomic factors affect the selection of proton radiation therapy for children.
    Cancer. 2017;123:4048-4056.
    PubMed     Text format     Abstract available


  22. SLOOT S, Chen YA, Zhao X, Weber JL, et al
    Improved survival of patients with melanoma brain metastases in the era of targeted BRAF and immune checkpoint therapies.
    Cancer. 2017 Oct 12. doi: 10.1002/cncr.30946.
    PubMed     Text format     Abstract available


  23. MILLER JJ, Shih HA, Andronesi OC, Cahill DP, et al
    Isocitrate dehydrogenase-mutant glioma: Evolving clinical and therapeutic implications.
    Cancer. 2017 Oct 5. doi: 10.1002/cncr.31039.
    PubMed     Text format     Abstract available


    September 2017
  24. HAN CH, Batchelor TT
    Diagnosis and management of primary central nervous system lymphoma.
    Cancer. 2017 Sep 26. doi: 10.1002/cncr.30965.
    PubMed     Text format     Abstract available


  25. ARBOUR KC, Kris MG, Riely GJ, Ni A, et al
    Twice weekly pulse and daily continuous-dose erlotinib as initial treatment for patients with epidermal growth factor receptor-mutant lung cancers and brain metastases.
    Cancer. 2017 Sep 21. doi: 10.1002/cncr.30990.
    PubMed     Text format     Abstract available



  26. Wearable medical device improves survival for glioblastoma patients.
    Cancer. 2017;123:3433.
    PubMed     Text format    


  27. BENZ LS, Wrensch MR, Schildkraut JM, Bondy ML, et al
    Quality of life after surgery for intracranial meningioma.
    Cancer. 2017 Sep 13. doi: 10.1002/cncr.30975.
    PubMed     Text format     Abstract available


  28. DIAO K, Sun Y, Yoo SK, Yu C, et al
    Safety-net versus private hospital setting for brain metastasis patients treated with radiosurgery alone: Disparities in follow-up care and outcomes.
    Cancer. 2017 Sep 13. doi: 10.1002/cncr.30984.
    PubMed     Text format     Abstract available


  29. BLUM MURPHY M, Xiao L, Patel VR, Maru DM, et al
    Pathological complete response in patients with esophageal cancer after the trimodality approach: The association with baseline variables and survival-The University of Texas MD Anderson Cancer Center experience.
    Cancer. 2017 Sep 8. doi: 10.1002/cncr.30953.
    PubMed     Text format     Abstract available


    July 2017
  30. WAHL M, Chang SM, Phillips JJ, Molinaro AM, et al
    Probing the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway in gliomas: A phase 2 study of everolimus for recurrent adult low-grade gliomas.
    Cancer. 2017 Jul 31. doi: 10.1002/cncr.30909.
    PubMed     Text format     Abstract available


  31. FIELD KM, Phal PM, Fitt G, Goh C, et al
    The role of early magnetic resonance imaging in predicting survival on bevacizumab for recurrent glioblastoma: Results from a prospective clinical trial (CABARET).
    Cancer. 2017 Jul 5. doi: 10.1002/cncr.30838.
    PubMed     Text format     Abstract available


  32. SATO M, Gunther JR, Mahajan A, Jo E, et al
    Progression-free survival of children with localized ependymoma treated with intensity-modulated radiation therapy or proton-beam radiation therapy.
    Cancer. 2017;123:2570-2578.
    PubMed     Text format     Abstract available


  33. ALVAREZ E, Keegan T, Johnston EE, Haile R, et al
    Adolescent and young adult oncology patients: Disparities in access to specialized cancer centers.
    Cancer. 2017;123:2516-2523.
    PubMed     Text format     Abstract available


    June 2017
  34. WESTPHAL D, Glitza Oliva IC, Niessner H
    Molecular insights into melanoma brain metastases.
    Cancer. 2017;123.
    PubMed     Text format     Abstract available


  35. JOHNSON DB, Sullivan RJ, Menzies AM
    Immune checkpoint inhibitors in challenging populations.
    Cancer. 2017;123:1904-1911.
    PubMed     Text format     Abstract available


    May 2017
  36. LEHMANN V, Tuinman MA, Keim MC, Winning AM, et al
    Psychosexual development and satisfaction in long-term survivors of childhood cancer: Neurotoxic treatment intensity as a risk indicator.
    Cancer. 2017;123:1869-1876.
    PubMed     Text format     Abstract available


    April 2017
  37. AMSBAUGH MJ, Yusuf MB, Gaskins J, Burton EC, et al
    Patterns of care and predictors of adjuvant therapies in elderly patients with glioblastoma: An analysis of the National Cancer Database.
    Cancer. 2017 Apr 27. doi: 10.1002/cncr.30730.
    PubMed     Text format     Abstract available


  38. DEFILIPP Z, Li S, El-Jawahri A, Armand P, et al
    High-dose chemotherapy with thiotepa, busulfan, and cyclophosphamide and autologous stem cell transplantation for patients with primary central nervous system lymphoma in first complete remission.
    Cancer. 2017 Apr 3. doi: 10.1002/cncr.30695.
    PubMed     Text format     Abstract available


  39. KAWAMURA J, Kamoshida S, Shimakata T, Hayashi Y, et al
    Filter paper-assisted cell transfer (FaCT) technique: A novel cell-sampling technique for intraoperative diagnosis of central nervous system tumors.
    Cancer. 2017;125:277-282.
    PubMed     Text format     Abstract available


  40. YANEZ ML, Miller JJ, Batchelor TT
    Diagnosis and treatment of epidural metastases.
    Cancer. 2017;123:1106-1114.
    PubMed     Text format     Abstract available


    February 2017
  41. FISCHER-VALUCK BW, Chen I, Srivastava AJ, Floberg JM, et al
    Assessment of the treatment approach and survival outcomes in a modern cohort of patients with atypical teratoid rhabdoid tumors using the National Cancer Database.
    Cancer. 2017;123:682-687.
    PubMed     Text format     Abstract available


  42. LANIER JC, Abrams AN
    Posterior fossa syndrome: Review of the behavioral and emotional aspects in pediatric cancer patients.
    Cancer. 2017;123:551-559.
    PubMed     Text format     Abstract available


  43. MILLER JA, Kotecha R, Ahluwalia MS, Mohammadi AM, et al
    Overall survival and the response to radiotherapy among molecular subtypes of breast cancer brain metastases treated with targeted therapies.
    Cancer. 2017 Feb 13. doi: 10.1002/cncr.30616.
    PubMed     Text format     Abstract available


  44. SANDLER KA, Shaverdian N, Cook RR, Kishan AU, et al
    Treatment trends for patients with brain metastases: Does practice reflect the data?
    Cancer. 2017 Feb 8. doi: 10.1002/cncr.30607.
    PubMed     Text format     Abstract available


  45. ACQUAYE AA, Vera E, Gilbert MR, Armstrong TS, et al
    Clinical presentation and outcomes for adult ependymoma patients.
    Cancer. 2017;123:494-501.
    PubMed     Text format     Abstract available


    January 2017
  46. PRINTZ C
    Device rapidly measures cell growth and can help determine drug resistance in cancer.
    Cancer. 2017;123:10-11.
    PubMed     Text format    


    November 2016
  47. DUNN-PIRIO AM, Vlahovic G
    Immunotherapy approaches in the treatment of malignant brain tumors.
    Cancer. 2016 Nov 22. doi: 10.1002/cncr.30371.
    PubMed     Text format     Abstract available


    October 2016
  48. BOELE FW, Given CW, Given BA, Donovan HS, et al
    Family caregivers' level of mastery predicts survival of patients with glioblastoma: A preliminary report.
    Cancer. 2016 Oct 27. doi: 10.1002/cncr.30428.
    PubMed     Text format     Abstract available



  49. Erratum: Pallini R, Ricci-Vitiani L, Montano N, Mollinari C, Biffoni M, Cenci T, Pierconti F, Martini M, De Maria R and Larocca LM. Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis. Cancer. 2011;117:162-17
    Cancer. 2016;122:3090.
    PubMed     Text format    


    September 2016
  50. CALDARELLA A, Barchielli A
    Glioblastoma in the Canton of Zurich, Switzerland revisited: 2005 to 2009.
    Cancer. 2016 Sep 13. doi: 10.1002/cncr.30341.
    PubMed     Text format    


  51. GRAMATZKI D, Weller M
    Reply to glioblastoma in the Canton of Zurich, Switzerland revisited: 2005 to 2009.
    Cancer. 2016 Sep 13. doi: 10.1002/cncr.30340.
    PubMed     Text format    


    August 2016
  52. SHOUSHTARI AN, Munhoz RR, Kuk D, Ott PA, et al
    The efficacy of anti-PD-1 agents in acral and mucosal melanoma.
    Cancer. 2016 Aug 17. doi: 10.1002/cncr.30259.
    PubMed     Text format     Abstract available


    June 2016
  53. DASENBROCK HH, Devine CA, Liu KX, Gormley WB, et al
    Thrombocytopenia and craniotomy for tumor: A National Surgical Quality Improvement Program analysis.
    Cancer. 2016;122:1708-17.
    PubMed     Text format     Abstract available


    May 2016
  54. VERMA V, Mishra MV, Mehta MP
    A systematic review of the cost and cost-effectiveness studies of proton radiotherapy.
    Cancer. 2016;122:1483-501.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: